vs
INSMED Inc（INSM）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
INSMED Inc的季度营收约是ROGERS CORP的1.3倍（$263.8M vs $200.5M），ROGERS CORP净利率更高（2.2% vs -124.5%，领先126.7%），INSMED Inc同比增速更快（152.6% vs 5.2%），ROGERS CORP自由现金流更多（$1.1M vs $-264.2M），过去两年INSMED Inc的营收复合增速更高（86.9% vs -3.3%）
Insmed Inc.是一家全球性生物制药公司，专注于为存在高度未满足医疗需求的严重罕见病患者开发、商业化创新疗法，核心布局肺部、内分泌类罕见病治疗赛道，服务覆盖北美、欧洲及亚太地区的患者群体。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
INSM vs ROG — 直观对比
营收规模更大
INSM
是对方的1.3倍
$200.5M
营收增速更快
INSM
高出147.4%
5.2%
净利率更高
ROG
高出126.7%
-124.5%
自由现金流更多
ROG
多$265.3M
$-264.2M
两年增速更快
INSM
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $263.8M | $200.5M |
| 净利润 | $-328.5M | $4.5M |
| 毛利率 | 83.2% | 32.2% |
| 营业利润率 | -121.2% | — |
| 净利率 | -124.5% | 2.2% |
| 营收同比 | 152.6% | 5.2% |
| 净利润同比 | -39.5% | 421.4% |
| 每股收益（稀释后） | $-1.55 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INSMROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $263.8M | $201.5M | ||
| Q3 25 | $142.3M | $216.0M | ||
| Q2 25 | $107.4M | $202.8M | ||
| Q1 25 | $92.8M | $190.5M | ||
| Q4 24 | $104.4M | $192.2M | ||
| Q3 24 | $93.4M | $210.3M | ||
| Q2 24 | $90.3M | $214.2M |
净利润INSMROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-328.5M | $4.6M | ||
| Q3 25 | $-370.0M | $8.6M | ||
| Q2 25 | $-321.7M | $-73.6M | ||
| Q1 25 | $-256.6M | $-1.4M | ||
| Q4 24 | $-235.5M | $-500.0K | ||
| Q3 24 | $-220.5M | $10.7M | ||
| Q2 24 | $-300.6M | $8.1M |
毛利率INSMROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 83.2% | 31.5% | ||
| Q3 25 | 79.4% | 33.5% | ||
| Q2 25 | 73.9% | 31.6% | ||
| Q1 25 | 77.1% | 29.9% | ||
| Q4 24 | 75.0% | 32.1% | ||
| Q3 24 | 77.3% | 35.2% | ||
| Q2 24 | 76.8% | 34.1% |
营业利润率INSMROG
| Q1 26 | — | — | ||
| Q4 25 | -121.2% | 3.5% | ||
| Q3 25 | -257.1% | 7.3% | ||
| Q2 25 | -291.3% | -33.3% | ||
| Q1 25 | -267.3% | -0.2% | ||
| Q4 24 | -220.6% | -6.6% | ||
| Q3 24 | -228.4% | 6.9% | ||
| Q2 24 | -319.8% | 5.3% |
净利率INSMROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -124.5% | 2.3% | ||
| Q3 25 | -260.0% | 4.0% | ||
| Q2 25 | -299.5% | -36.3% | ||
| Q1 25 | -276.4% | -0.7% | ||
| Q4 24 | -225.5% | -0.3% | ||
| Q3 24 | -236.0% | 5.1% | ||
| Q2 24 | -332.8% | 3.8% |
每股收益（稀释后）INSMROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-1.55 | $0.20 | ||
| Q3 25 | $-1.75 | $0.48 | ||
| Q2 25 | $-1.70 | $-4.00 | ||
| Q1 25 | $-1.42 | $-0.08 | ||
| Q4 24 | $-1.30 | $-0.04 | ||
| Q3 24 | $-1.27 | $0.58 | ||
| Q2 24 | $-1.94 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $195.8M |
| 总债务越低越好 | $546.8M | — |
| 股东权益账面价值 | $739.0M | $1.2B |
| 总资产 | $2.3B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.74× | — |
8季度趋势，按日历期对齐
现金及短期投资INSMROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $1.4B | $197.0M | ||
| Q3 25 | $1.7B | $167.8M | ||
| Q2 25 | $1.9B | $157.2M | ||
| Q1 25 | $1.2B | $175.6M | ||
| Q4 24 | $1.4B | $159.8M | ||
| Q3 24 | $1.5B | $146.4M | ||
| Q2 24 | $1.2B | $119.9M |
总债务INSMROG
| Q1 26 | — | — | ||
| Q4 25 | $546.8M | — | ||
| Q3 25 | $546.8M | — | ||
| Q2 25 | $546.8M | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $971.8M | — | ||
| Q2 24 | $1.2B | — |
股东权益INSMROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $739.0M | $1.2B | ||
| Q3 25 | $945.6M | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $99.2M | $1.3B | ||
| Q4 24 | $285.4M | $1.3B | ||
| Q3 24 | $483.4M | $1.3B | ||
| Q2 24 | $38.8M | $1.3B |
总资产INSMROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.3B | $1.4B | ||
| Q3 25 | $2.4B | $1.4B | ||
| Q2 25 | $2.5B | $1.5B | ||
| Q1 25 | $1.8B | $1.5B | ||
| Q4 24 | $2.0B | $1.5B | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $1.8B | $1.5B |
负债/权益比INSMROG
| Q1 26 | — | — | ||
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.58× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 11.31× | — | ||
| Q4 24 | 3.93× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 30.66× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-247.6M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $-264.2M | $1.1M |
| 自由现金流率自由现金流/营收 | -100.1% | 0.5% |
| 资本支出强度资本支出/营收 | 6.3% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $-967.6M | $70.1M |
8季度趋势，按日历期对齐
经营现金流INSMROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $-247.6M | $46.9M | ||
| Q3 25 | $-219.8M | $28.9M | ||
| Q2 25 | $-205.6M | $13.7M | ||
| Q1 25 | $-262.1M | $11.7M | ||
| Q4 24 | $-196.0M | $33.7M | ||
| Q3 24 | $-180.9M | $42.4M | ||
| Q2 24 | $-123.0M | $22.9M |
自由现金流INSMROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $-264.2M | $42.2M | ||
| Q3 25 | $-222.2M | $21.2M | ||
| Q2 25 | $-209.1M | $5.6M | ||
| Q1 25 | $-272.2M | $2.1M | ||
| Q4 24 | $-202.8M | $18.3M | ||
| Q3 24 | $-184.6M | $25.2M | ||
| Q2 24 | $-129.7M | $8.8M |
自由现金流率INSMROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | -100.1% | 20.9% | ||
| Q3 25 | -156.1% | 9.8% | ||
| Q2 25 | -194.6% | 2.8% | ||
| Q1 25 | -293.2% | 1.1% | ||
| Q4 24 | -194.1% | 9.5% | ||
| Q3 24 | -197.6% | 12.0% | ||
| Q2 24 | -143.6% | 4.1% |
资本支出强度INSMROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 6.3% | 2.3% | ||
| Q3 25 | 1.7% | 3.6% | ||
| Q2 25 | 3.2% | 4.0% | ||
| Q1 25 | 10.8% | 5.0% | ||
| Q4 24 | 6.5% | 8.0% | ||
| Q3 24 | 3.9% | 8.2% | ||
| Q2 24 | 7.5% | 6.6% |
现金转化率INSMROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
